Bayer Healthcare and Russian drug manufacturer Medsintez have teamed up to manufacture and market diagnostic imaging products and pharmaceuticals to treat infections and neural disorders, while also collaborating in joint research, Bayer said.
The companies will work together to research, develop, and produce new substances and medicines with the goal of speeding up access of new pharmaceuticals to the Russian population, the companies said.
The manufacturing partnership will launch with full-cycle manufacturing of antibiotics Avelox and Ciprobay, Nomotop for neural disorder, and an array of diagnostic imaging products, the company said.
Local production is expected to boost the firm's business development activities in a key growth market, Bayer said, ultimately strengthening the firm's competitive position.
